Infectious Disease PractitionerAASLD: Pilot study shows value of response-guided therapy for HCV GT1bNovember 18, 2015Hepatitis
Infectious Disease PractitionerElevated liver cancer risk after HCV cure may justify surveillanceNovember 18, 2015Hepatitis
Infectious Disease PractitionerInvestigational hepatitis B therapy shows activity in proof-of-concept studyNovember 18, 2015Hepatitis
Infectious Disease PractitionerTransplant waiting-list registrations dropped after direct acting–antiviral approvalNovember 18, 2015Hepatitis
Infectious Disease PractitionerInterferon-free treatment combo looks promising for HCV GT2, GT3 infectionNovember 18, 2015Hepatitis
Infectious Disease PractitionerVIDEO: 12-week HCV retreatment effective if short course failsNovember 18, 2015Hepatitis
Infectious Disease PractitionerCDC encourages improved antibiotic stewardshipNovember 18, 2015Antimicrobial-resistant infections
Infectious Disease PractitionerSofosbuvir/R yields benefits in compassionate use HCV programNovember 17, 2015Hepatitis
Infectious Disease PractitionerVIDEO: Longer HCV therapy worked even after short-term failuresNovember 17, 2015Hepatitis
Infectious Disease PractitionerMultitargeted drug combination promising when new HCV antivirals failNovember 17, 2015Hepatitis
Infectious Disease PractitionerRegimen effective in genotype 3 HCV despite advanced cirrhosisNovember 17, 2015Hepatitis
Infectious Disease PractitionerVIDEO: Antigen test could simplify HCV screeningNovember 17, 2015International IDHepatitis
Infectious Disease PractitionerVIDEO: Inappropriate hepatitis A, B tests may be widespread in hospitalsNovember 17, 2015Hepatitis
Infectious Disease PractitionerASTRAL-1: High SVR12 with sofosbuvir/velpatasvir combo for HCVNovember 17, 2015Hepatitis
Infectious Disease PractitionerHigh SVR achieved in decompensated HCV patients with 12-week therapyNovember 17, 2015Hepatitis